지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록· 키워드
오류제보하기
The goals of management of stable chronic obstructive pulmonary disease (COPD) are to reduce both current symptoms and future risks with minimal side effects from treatment. Identification and reduction of exposure to risk factors are important in the treatment and prevention of COPD. Appropriate pharmacologic therapy can reduce symptoms and exacerbations, and improve health status and exercise tolerance. To date, none of the existing medications for COPD has been shown to modify disease progression or reduce mortality. The classes of medication are bronchodilators including beta2-agonist, anticholinergics and anti-inflammatory drug including inhaled corticosteroid and phosphodiesterase-4 inhibitor such as roflumilast. Each treatment regimen needs to be individualized as the relationship between severity of symptoms, airflow limitation and severity of exacerbation can differ between patients.
목차
등록된 정보가 없습니다.
참고문헌 (40)
참고문헌 신청
Burge PS / 2000 / Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial / BMJ 320:1297~1303
Anthonisen NR / 1994 / Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of $FEV_1$ : the Lung Health Study / JAMA 272:1497~1505
박용범 / 2018 / Revised (2018) COPD Clinical Practice Guideline of the Korean Academy of Tuberculosis and Respiratory Disease: A Summary / Tuberculosis and Respiratory Diseases 81(4):261~273
Sinthia Zrinka Bosnic-Anticevich,B.Pharm. / 2018 / Continued Innovation in Respiratory Care: The Importance of Inhaler Devices / Tuberculosis and Respiratory Diseases 81(2):91~98
유광하 / 2017 / Short-term Evaluation of a Comprehensive Education Program Including Inhaler Training and Disease Management on Chronic Obstructive Pulmonary Disease / Tuberculosis and Respiratory Diseases 80(4):377~384
Anthonisen NR / 1994 / Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of
박용범 / 2018 / Revised (2018) COPD Clinical Practice Guideline of the Korean Academy of Tuberculosis and Respiratory Disease: A Summary / Tuberculosis and Respiratory Diseases 81(4):261~273
Sinthia Zrinka Bosnic-Anticevich,B.Pharm. / 2018 / Continued Innovation in Respiratory Care: The Importance of Inhaler Devices / Tuberculosis and Respiratory Diseases 81(2):91~98
유광하 / 2017 / Short-term Evaluation of a Comprehensive Education Program Including Inhaler Training and Disease Management on Chronic Obstructive Pulmonary Disease / Tuberculosis and Respiratory Diseases 80(4):377~384
이 논문의 저자 정보
최근 본 자료
댓글(0)
0